Archives

Writing your annual progress report is both an art and a science. T. Alp Ikizler, MD, mentor of so many early career faculty trainees he’s lost count and winner of the 2016 Award for Excellence in Mentoring Translational Scientists at Vanderbilt, shared his thoughts on how to put your best foot forward to your funding agency.

Stakeholders Want You to Succeed

Stakeholders in your grant include your Program Officer, your mentors, your lab group, and your institution. None of them are looking for ways to reject your progress report and refuse you the next year of funding. Dr. Ikizler has never seen a progress report get rejected, though EFS sources have seen PO’s come back with questions before accepting the report.

This is not to say funders will be uninvolved. Your funding agency’s level of involvement in your report and your career in general depends on the institute or agency, the type of science you do, and the PO’s personality and level of interest. Know your PO and what he or she expects. Only hearing from you when you turn in your annual report, quarterly check-ins, monthly phone calls? Give this person what they want, at the level of detail they want, and when they want it.

Consistency Is Key

For most progress reports, the first page contains the original aims from your application. If you’ve changed these aims, or anything else planned in your application, your most important job is to explain these changes. An aim may evolve because an experiment produced an unexpected outcome or a technique didn’t work like you thought it would. Maybe your primary mentor changed institutions and you had to find a new one. Perhaps a class you planned to take was canceled. Explain what happened and how you have adapted your plan to accommodate the changes. None of this is “your fault” and you won’t be penalized as long as you show you have adapted appropriately.

However, if you’re making changes of your own volition, the progress report is not the first place your PO should learn of them. Before engaging in a new collaboration, changing the direction of your research (unless you hit a snag), taking a new job, or becoming a co-investigator on someone else’s grant, speak with your PO.

This report should align with any other reports you send to your funder, such as quarterly DSMB reports or anything you put in ClinicalTrials.gov.

Maintain Focus

This report tells your stakeholders that you’re making progress on what you said you would do in your application. Note whether you’ve met the milestones you laid out in your career development section (or if not, then why not).

Don’t overexplain how your time is allocated. Simply state, “I have 75% [or more, if accurate] of my time protected for research, training, and career development activities.” List key career development activities you’ve done this year, then note that other activities are proceeding as planned. No need to get into the minutia of your clinic schedule, teaching load, or how much time you spend on any given activity.

Carefully consider how to address new collaborations and activities. These become more acceptable in later years of your career development grant, as you submit and resubmit applications for independent funding. It’s always helpful to explicitly link the things you’ve done in the past year with your plans for independence.

Avoid discussing activities that steal focus from your research and career development. Taking on administrative roles, for example, is rarely viewed favorably.  (Slightly different advice for VA CDA awardees: Taking an administrative role at the VA—preferably towards the end of your CDA—can increase your chances of receiving a VA Merit award.)

Document Everything

Note when you had mentoring committee meetings this year and who attended. If these meetings weren’t on the schedule you originally proposed, explain why.

Document Responsible Conduct of Research training (we suggest using this form). Remember this includes not only seminars or classes, but activities like training a new lab member in data management and recordkeeping, discussing authorship with colleagues, or asking your mentor for advice on a conflict of interest.

Include all your publications from the past year, even if they don’t directly relate to the science of this award; a career development award is a training grant and your publications reflect your career success, so they matter.

For NIH grants, all publications must have a PMCID.

Include links to any place your research has been covered in the media, including in press releases by your institution.

Include awards! Trainees often leave off prizes for posters or presentations. Your PO wants to know about them—your success makes the funding agency look wise for betting on you.

Edit, Edit, Edit

Edit your report thoroughly. Make sure your citation format is uniform and correct. Then send the report to your mentors. (A trainee progress report should never reach a funding agency without being seen by a mentor.)

Do you have tips for writing progress reports? Share them below.

More Resources

Designing Your Career

Not that Kind of Grant Application: Tales of Career Development Awards

How to Protect Your Protected Time

To compete well for grants, you need to know what’s getting funded.  Enter NIH Matchmaker.  The service takes text about your science and shows you the projects that are most like yours.  Reading the abstracts yields insight into the kinds of aims reviewers find attractive, and the study section and institute that most commonly fund your kind of science.

Matchmaker lives within the larger NIH Reporter site. You’ll see a text box to enter any content you want to match on. The character limit is 15,000, so not only could you use the abstract of a grant or conference presentation, but also almost an entire manuscript, a dissertation chapter, or similar. Some researchers hack the matchmaking algorithm by putting in a list of words related to their research, repeating the more important ones several times.  (I.e., “fibroids fibroids fibroids leiomyomata miscarriage pregnancy ultrasound ultrasound.”) Once you’ve entered your text, choose “Similar Projects.” (Can also check what comes up under “Similar Program Officials.”)

Click to view larger.

Matchmaker then returns up to 500 similar projects, listed in decreasing similarity (as indicated by the match score on the left). NIH provides info on how they calculate a match score (natural language processing using a combination of how frequently the term appears in the matched grant’s title, abstract, and aims, and how uncommon the word is across all grants). Click on “About RePORTER Data” and scroll to the bottom of that section.

Click on any project title to read the abstract, which typically provides a glimpse of the specific aims. Using the tabs at the top, you can see how much money the project received, which institute, program officer and study section it went through, and, if the project is far enough along, a list of papers linked to that particular grant.

Filter your results by any combination of institute, grant type (aka activity code), or study section using the bar graphs at the top of the results page. For example, in the results on the right, if you only wanted to see R01s funded by NICHD, you would click those two bars of the graphs. If you’re trying to decide between study sections to request, you can examine which grants on your match list have been funded by each of the study sections you’re considering by using the filters. (Guide to study section abbreviations.)

All of this information helps you reality check the attractiveness of the potential focus of your new grant and tailor your science and methods. This helps best align your grant application with the leading edge that NIH is funding right now–and when paylines are tight, you have to write what gets reviewers excited.

Additional Resources

Harness the Immense Power of Nosiness in NIH RePORTER

Using NIH RePORTER to Find Your Guide

Which Study Section Should I Pick? Try the Assisted Referral Tool!

Video: How to Use NIH Matchmaker

When submitting a grant, sixteen weeks out is the magic number for starting the process. (For the NIH deadlines, this means start working at the deadline before your target: For the June deadline, early February is the optimal time to begin, and so on.) Understanding the path and having a clear timeline is key to a successful grant submission that doesn’t leave you wrung out.

Dr. Carol Lorenz, aka Durango Kid, provides everything you need to pace your winter grant to successful submission.  With a history of managing more than 70 grant submissions in a year, Dr. Lorenz is a PhD scientist with guaranteed reality-based expertise in project management. Over the course of seven blog entries, she breaks down the huge endeavor of a grant submission into manageable chunks, and shows you how to create a customized grant timeline to ensure the smooth completion of your application.

Part 1: #*@*! Plan is Not a Four-Letter Word

Why should you do this? How can it help you? Assignment: Decide on which grant you want to apply for.

Part 2: Planning to Plan: Gathering Materials

How should you start your plan? Assignment: Assemble supplies for creating a paper timeline.

Part 3: Can You (Really) Do Your Proposed Study?

How to assess feasibility so you don’t bite off more than you can chew (or put into one application). Assignment: Create a project proposal.

Part 4: Researchers: Start Your Timelines

How much time do you really have, and how can you best break it down? Assignment: Add submission date and units of time to your timeline. For February 2022, we suggest these dates.

Part 5: 500 Mile(stones)

Milestones can tell you if you’re progressing at the right pace toward your submission due date. Assignment: Note important dates and transfer them to your timeline.

Part 6: Buckets of Fun (Work?)

How to break your work into packages so you can then define specific tasks. Assignment: Create your buckets.

Part 7: What’s In Your Bucket(s)?

Now that you have your buckets, what do you put in them? Assignment: Brainstorm tasks and fill your buckets, then your timeline.

An example of a completed timeline (click for full size).

More Resources

Ten Insider Tips: What Your Grants Manager Wishes You Knew

More Things I Wish I’d Known Before I Wrote My K

Three (Grant) Peeves in a Pod: Write Better

For most grants you write, here is all you need to do to get them funded:

1. Convince me that it will be a crime against humanity if the science doesn’t get done, and that

2. No one in the world besides you can do it.

Simple.

For grants with a clinical trial, though, there is one more thing that you have to do, which seems simple when I say it, but people still screw it up continuously.

3. Get the statistics and recruitment right.

For clinical trials, (1) is usually pretty easy – by the time you’re proposing a clinical trial, you presumably have a mountain of preclinical evidence on the efficacy of whatever you’re proposing in a variety of animal models, you’ve probably got some safety data, and you’ve got a molecular mechanism that’s compelling. Nine out of ten reviewers are going to agree with you that it’s time to bring it into humans.

And then you blow it by setting up your trial design and statistics in such a way that you convince reviewers that no matter what happens, you’re not going to end with meaningful data.  Your recruitment assumes literally everyone who comes through your clinic agrees to participate (or you don’t say how many people are coming through your clinic at all). Your recruitment requires you to be recruiting 24/7 – but you don’t even have a clinical coordinator, let alone a research nurse or two.  Are you gonna sleep in the ER?

You power it based on wildly optimistic assumptions of efficacy – one clinical grant I recently reviewed required tenfold higher effectiveness than any other drug ever tested in order for detectable effect. You ignore effects of other treatments, or variability in the etiology of the underlying disease, in your inclusion/exclusion criteria (shock from blunt trauma ain’t the same as shock from burns and shock from infection). You include subgroup analyses you’re really not powered for. You include large numbers of secondary endpoints without telling me how you’re correcting for multiple testing (I like lots of endpoints, but you need to be careful with them statistically).

Your statistics section was obviously stolen from some other grant, so it has statistics-sounding words, that don’t make sense in current context.

Many authors don’t get power right:

https://elifesciences.org/articles/34412/figures

Two big pieces of advice:

• If you’re not expert on it yourself, get a biostatistician involved in your trial design right from the start. Don’t just get someone to give you their CV to include.
• Get somebody who’s actually run a trial to help with the design and recruitment strategy. It’ll keep you from making the sorts of mistakes that call into question your ability to complete the study.

I just came off of a study section that was nothing but reviews of clinical trials. Essentially every one of them had these problems – and we all loved the premise and preliminary data on all of them. What that means is, get this piece right, and you’ve got a big jump on the competition.

This post condenses a Q&A led by Alex Smith, MD, MS, MPH and Katherine Hartmann, MD, PhD, on the topic of K to R conversion at the annual 2018 meeting of the Paul B. Beeson Emerging Leaders Career Development Awards in Aging. The round table included Beeson Scholars, who are K awardees, their mentors and other leaders from academic medicine and the NIH. The goals of the meeting include building the aging research community, encouraging dissemination of findings, and enhancing development of scholarship and leadership.

Q.  I’ve been advised to write an R03 to have more funding and show that I can achieve my own NIH funding. Is that a good starting place?

Several facets need consideration:

• While having an R03 or R21 could provide a bit of a halo effect in subsequent reviews, other reviewers will wonder why a career development awardee did not get straight into the game.
• Being a productive independent investigator requires substantial funding over extended periods. R01s and equivalent large grants are an accepted (if contentious) gold standard for achieving independence. Pragmatically, they also provide the funds needed to build and sustain a research team, which is a fundamental need for a successful transition.
• R03s and R21s are simply not long enough and don’t carry enough funding to build a research enterprise. You are in essence an entrepreneur and must launch rapidly.
• Hypothetically if you were ready on the first day of your career development award to submit a smaller grant, bear in mind that R03s and R21s are slightly harder to get than R01s. Per NIH’s Funding Facts, success rates over the past five fiscal years for R21s are around 13.5%, and R03s around 17%. The R01 success rate for most years is 18%. Study this data for your institute.
• “High-risk, high-yield” and note of lower requirements for preliminary data for R21s does not equate to “perfect for early career researchers.” The majority of R21s go to established labs because they are a strong bet for the funding gamble to pay off.  Most often the award demonstrates novel techniques or tools within a thriving research portfolio.
• R03s/R21 are equally as slow to obtain as R01s. Because resubmission is nearly guaranteed, time from first submission to receipt of funds can take 18 months or longer. You can’t wait that long to conduct research to support your first R01 submission. You need more immediate pilot funds if your K cannot support key research components.
• It’s very difficult to generate data, get it published, and integrate it into an R01 application in the short time frame of these grants because of the delay built into receiving an award. In the session prior to this discussion we created timelines that demonstrated that K-awardees with a five year grant need to submit a first R01 no later than the middle of the third year of funding to allow for revision and resubmission. Optimally you’ll submit earlier (see discussion of overlap of K and R below).

Q. What is the place for R03 and R21 grants?

• To branch out from your current line of research and build a base to move to a new area.
• To validate a method, do a feasibility study, or pursue another set of experiments or analyses that aren’t enough to drive an entire R01.
• To pull out a strong aim from an R01 application that got mixed reviews and turn the well-reviewed aim into an R03 while you regroup for the R01.

Q. I’ve been told I don’t want to get an R01 too early. Won’t I lose my K award?

• Creating a timeline is very informative: map when you will finish crucial data collection, when you will submit key materials for publication, and when you anticipate being ready to submit an R01 award. Be sure not to think only in terms of scientific readiness. Allow 16-20 weeks to prepare all the components of the grant including details like staffing, subcontracts, letters of support, and locking in co-investigators. Then allow for the NIH review and resubmission dates, remembering to extend the horizon past review to dates of council and possible start of funding.
• It is rare that K awardees are ready to play professional ball, aka submit an R01, in the first year or two of preparation. Few individuals need to worry about going too fast. Most need to worry (based on timeline above) about starting too late.
• Career development awards pay for the scientist, not the science. Wouldn’t you rather have a larger budget for your science and for key personnel in your research group?
• Federal career development awards allow for up to two years of overlap of a K award with an R01. This is magic because it preserves a high level of protected time (which you will never again receive on a single R award) to learn how to play and hire and coach your team on your way to complete independence and smooth function.
• Anecdotally, a mentor in the group noted an extremely unusual K awardee who submitted an R01 around 8 months into her K award and was funded on the first submission. The hypothetical question: was she was worse off? Of course not; she still had two additional years of 75% protected time and $2.7 million to seriously drive her science and build a bigger team. It also came with the psychological advantage of not chasing independence close to tenure and promotion review.

Q. How much preliminary data do I need to support an R01?

• It’s not just about data. You do need to support claims as strongly as possible – provide actual data in the grant. Do not expect reviewers to go look at your papers. They will, but for other reasons. They expect you to distill key information in the text.
• Remember reviewers consider many categories of information to judge if you are prepared to conduct an R01-scope study. The rationale and scientific thought model must be airtight and clear and the approach must be attractive. Beyond that reviewers will also consider whether you have:

1. Shown them that you and your team are capable of doing the technical aspects of the work. [feasibility]
2. Published work that supports your hypotheses or led to your hypotheses. [evidence]
3. Published work that demonstrates #1 above. [proof of technical ability]
4. Embedded unpublished findings in your application that support your hypotheses or demonstrate feasibility.
5. Provided publications, data, or letters from others that support hypotheses or feasibility.
6. Argued effectively from analogy to similar model systems or study approaches that you are likely to succeed.
7. Recruited similar participants (or acquired similar specimens) at the proposed pace. [proof of concept]
8. Led studies of comparable design or complexity even if on another topic. [capability/experience]
9. Completed key approvals that could slow or prevent the research such as IRB approval, protocol registration, or IND documentation. [administrative readiness]
10. Research team of sufficient skill to do the described work.
11. Have in place key infrastructure such as databases, electronically programmed and ready to administer instruments for human subjects, quality control procedures for assays, training manuals, etc. that will be required to function rapidly at the highest level. [functional readiness]
12. Collaborators who are contributing their expertise to your work (as opposed to giving the impression you are continuing the work of a mentor).
13. Calls from national organizations, NIH, and/or thought leaders for the work you are proposing, suggesting it is valid and important.

• Ask yourself, have I provided what they need to know across my entire grant from the abstract to body, budget justification and biosketches that convinces them I am capable and ready to do this work?
• Get experienced reviewers to candidly review your grant, asking specifically, have I convinced you this is important, well-founded, and do-able?

Q. Should I aim for a specific RFA? 

• A PA – program announcement – yes. An RFA, generally, no.
• Exceptions to avoiding RFAs for first grant applications would include calls seeking specific candidates such as under-represented minorities working in a narrow content area or instances in which your work or comparable work is cited in the RFA as the foundation for the focus of the RFA. Be sure experienced mentors read it the same way.
• Remember many RFAs are “wired” to draw out particularly strong existing teams. Program officers are in an awkward situation of knowing this is typical but not being able to state that it is a pattern. You will go up against bigger dogs for limited resources.
• If the RFA does not allow resubmission, aka is a one-time offer, be especially cautious.
• Rarely, a team led by an early career investigator can justify responding to an RFA if it will drive them to move faster towards completing a research protocol and preparing a related grant. If you and collaborators would write exactly the same grant with or without the existence of the RFA it might be a more logical choice. But don’t lose sight of the timeline. Even a well-targeted diversion is still a diversion since you will not be able to submit the work as an investigator initiated RPG until the proposals solicited in the RFA are reviewed. And in some cases of uncertain score, awaiting a decision of NIH Council can further delay teams.

More Resources

BioScience Writers – Should I Apply for an R01, R03, or R21 NIH Grant Award?

NIAID – Comparing Popular Research Project Grants: R01, R03, or R21 (Key quote: “R21 projects should be distinct from those supported through the traditional R01 and are not intended as a bridge between training and obtaining an R01 grant.”)

Your grants manager is a key person in ensuring smooth submission of your grant. Here’s what every grants manager wants you to know:

1. Notify your grants manager at the very beginning of the grant writing process. This will help them schedule their time and give your grant the necessary attention.

2. Start working with your grants manager 6-8 weeks ahead of the submission date. Familiarize yourself with your institution’s specific guidelines for routing and submission.

3. Read the program announcement, or RFA, carefully and know the requirements and limitations. Make sure you are eligible to apply and the work you are proposing is doable with the resources available.

4. The grants manager should provide a list of requirements including who does what. If you do not receive this document, ask them to provide one.

5. For R01s and other non-career development grants, the budget is a key component of the grant and can be time consuming to build, especially if there are subcontracts. Start the budget early!

6. Make sure you are using the most recent and appropriate forms.

7. Ask people to be on the grant and have their permission to include them before giving their names to the grants manager.

8. Understand the different roles people can play on a grant: Co-PI, co-investigator, collaborator, consultant, and other significant contributor. (NIH definitions).

9. If you make changes to the title, budget, or other key components, let your grants manager know right away. Late changes, especially to the budget, may require modification of various other grant components.

10. Get to know your grants manager – they are dedicated to helping you succeed. And most of them like treats, especially chocolate.

Thank you to Pattie Council and Suellen Sachariat for their combined 20 years of grants management experience and sharing their expert knowledge with Edge for Scholars.

More Resources

Mapping the Path for K (or R) Submission

More Things I Wish I’d Known Before I Wrote My K

Try the NIH “All About Grants” Podcast

Four recipients of K24 Midcareer Investigator Award in Patient-Oriented Research awards shared their best advice for writing these grants that protect time for independent investigators at the Assistant or Associate Professor level to mentor. (More on why you should write a K24.)

Panelists at this Vanderbilt event:

What Is a K24, Why Do You Need One, and When Should You Apply?

Success rates for fiscal year 2021 across NIH institutes offering K24s. Data from NIH RePORT.

• A K24 is a midcareer award that protects 25-50% of your time for mentoring and learning a new skill or expanding on an existing skill.
• Eligible applicants are at the Assistant or Associate Professor level, R01 (or equivalent)-funded, and doing patient-oriented research.
• Patient-oriented research involves direct contact with patients (not just the EMR or biospecimens).
• PhDs and MDs are eligible.
• Not all institutes offer one, and those that do have different rules about renewals, allowed effort, and other components.
• Success rates are very high—typically over 45%, sometimes up to 100%. Many are funded on the first try.
• Think about timing of a K24 submission in relationship to your own grant funding cycles and promotion timeline.
• When you’re ready for the responsibility of mentoring postdocs or K scholars (which equals responsibility for someone else’s career!), this will protect your time to do it.

Do and Consider Before Writing

• Search RePORTER for funded K24s in your institute—very helpful for getting a sense of the scope of projects proposed by others and how to uniquely position yourself.
• Solicit advice from others with K24s.
• Before you apply, honestly appraise your mentoring track record. Can you show mentoring success? What kind of impact have you had on people who trained with you even for a short time?
• Know your local department and your field—how many people are like you?
• Select the specific group of people you want to mentor; make sure it fills a need and fits with institution priorities. External mentorship counts—use professional organizations’ mentoring programs.
• Make sure you have research projects available at the right level for the people you propose to train, from medical or graduate students to fellows to K scholars. You will need to show how your mentees can create a niche for themselves and propel their career, rather than simply extending your research program.
• Strategically plan for what you will give up (or negotiate to give up) if your K24 is funded so that you have protected time for mentoring.
• Get involved with national projects that show leadership and mentoring, such as organizing a Gordon conference, leading a workshop at the big meeting in your field, or blogging on Edge for Scholars. Not only can you highlight it in your application, you can also request letters of support from others involved.
• Talk with your program officer.
• Read institute goals and align your application with them. Make sure you read the most current. Institutes frequently revise these programs based on institutional priorities.
• As with R01s, sometimes your grant might fit more than one institute, and you can tweak your application for the one with a better payline. Your K24 does not have to be through the same institute as your R01.

Shape Your Mentoring and Learning Strategies

• Decide whether you want to and can best make a case for learning a new skill or technique vs. developing a logical extension of your current skillset. Make an argument about how this will drive your career.
• Your proposed research must meet the definition of patient-oriented, but consider applying even if you have a track record in basic or translational research if you can make the case for how this will propel your career development and that of your mentees.
• One panelist’s reviewers considered it a minor weakness to not list a senior mentor.
• Choosing a primary mentor:
  • Choose someone not on your K23/K08.
  • Thematically look at investigators who can provide new ideas and new approaches to your research efforts.
  • Look at mentors who are successful.
  • Consider a mentoring committee rather than a single individual.
  • Consider external expertise for members of a committee.
• Prior to writing, discuss with local training infrastructure leaders how to take advantage of both mentoring opportunities and supports available through your institution, as well as the resources your mentees can access.
• Specify how you will find mentees. Think outside your own discipline, and even outside your institution.
• Consider how mentees will be able to develop their own niche and eventually become independent.

Write the Application

• Think of this grant as one big personal statement and resume. Find your story.
• You might write this grant in a non-standard order. One panelist wrote most of the grant with a relatively underdeveloped Aims page, and then did a lot of Aims page work and realigned rather late in the grant writing process.
• Consider using the instructions or even copying the required section headers into the application, as this grant is in a non-traditional format compared with what many reviewers are accustomed to reviewing.
• Clarify what you will not do in order to focus on mentoring and research, and have your chair put this in writing in his or her letter.
• Your mentoring history is really important—be sure to showcase trainee awards, funding, publications and current (hopefully academic/research) positions. Keep up with your mentees.
• Have a clear vision of what is next. How will you use the skills you develop, and what is your next step as a mentor?
• Some propose to write a T32 or K12 while on the K24; having a K24 in hand assures reviewers of training grants that you will have time to actually mentor those trainees.
• The research plan needs to build upon your funded research program that is already in place. Describe your program, how the proposed research builds upon it, and specifically how it supports trainee projects and their careers.
• If you elect to propose new research within the research plan, be aware that funds are limited and that a new project opens you up to critiques of the research project along with critiques of everything else in the application.
• The budget allows salary support to protect your time for mentoring and use of remaining support for components of your research program that can help to support mentees.
• Consider allocating budget for statistical support and research coordinator/nurse to support trainees especially. A K24 also reduces the salary support you must take on your R01(s), which frees up funds for trainees.

Do you have other advice for writers of K24s? Tell us in the comments below.

More Mentoring Ideas

Why You Want to Mentor via NRMN Guided Virtual Mentorships

It Is Never Too Early to Be a Mentor

Speed Mentoring: Seven Steps to a Successful Session

Success rates for 2018 & 2019 from NIH RePORTER. Click to view larger image.

Midcareer faculty often wish for more support and time to mentor, but many aren’t aware that NIH has a mechanism that does exactly that. K24 awards are the NIH’s best-kept secret. Many institutes have success rates of over 50%, some up to 80% or even 100%. If you’re an MD or PhD at the Assistant or Associate Professor level with an established, independent program of patient-oriented research and a solid track record of mentoring new clinical investigators, why wouldn’t you write a K24?

Here are the top five reasons to write a K24:

1. Get salary support for mentoring.

It takes time, energy, and a lot of work to be a good mentor. You remember the qualities of the mentor that helped you. Why not emulate the best of these, and get salary support for this work? The K24 will provide salary for levels of effort between 3-6 person-months (or between 25 and 50% full-time effort). There are different levels depending on the institute. It is important to read the different guidelines provided by each participating institute.

2. Grow academically.

Stagnant thinking is an impediment to your research and professional development. The K24 gives you an opportunity to think creatively about where you want your career to go. Do you want to learn a new skill or technique, or develop a logical extension of your current skillset? You can make a case for either. The K24 supports clinical research that directly engages human subjects. This could include studies of mechanisms of human disease, therapeutic interventions, clinical trials, or… (You don’t need a track record in clinical research to apply, by the way.)

3. Develop expertise in new technologies.

Innovation is vital to research progress. New techniques and methods require time and training. Perhaps you want to take this opportunity to develop expertise in a new research technique? The NIH will provide up to $50,000 per year for research expenses, travel to research meetings, training, and statistical services.

4. Explore new research avenues.

As always, the research description should emphasize novelty, significance, creativity, approach, and your ability to carry out the proposed research. Maybe you are a basic scientist who wants to study clinical populations, or you want to study a different disease-state. Take this opportunity to reorient or expand your research focus. The candidate background and career goals section provides a great opportunity to summarize where you have been and where you are going.

5. Invest in people.

Recreating yourself is the key (IMO) to avoiding burnout. Use this grant as an opportunity to do just this. My suggestion is to take a step away from the business of life, even if it is for a morning, and reflect on the importance of investing your time and energy in someone else’s life. Writing this grant becomes an opportunity to take stock of your current and aspirational mentoring approach. When you write the “candidate approach to mentoring” section, take the opportunity to reflect on your lab structure, mentoring approach, and how you will create an environment that invests in the lives of others.

Participating Institutions
NHLBI
NIA
NIAAA
NIAMS
NIAID
NIDCD
NIDA
NIEHS
NIMH
NINR
NCCIH

RFA for clinical trials.
RFA without clinical trials.

Are you writing a K24? If so, let us know what motivates you!

MORE RESOURCES

How to Get a K24

Microaffirmations

Scholarly Activities for a Remote Lab